Efficacy and Safety of Programmed Death-1/Programmed Death-1 Ligand Inhibitors in the Treatment of Renal Cell Cancer: a Meta-analysis
ZHANG Dongli, SHEN Chong, ZHANG Weichuan, CHEN Haibin, ZHAO Jianjun
Chinese General Practice . 2023, (30): 3815 -3822 .  DOI: 10.12114/j.issn.1007-9572.2023.0180

Website Copyright © Editorial Office of Chinese General Practice
Powered by Beijing Magtech Co., Ltd.